The announcement came after Republican gubernatorial candidates in New Jersey and Virginia faced a drubbing in Tuesdays election in which dour voter outlook about the economy appeared to an animating factor in the races
PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) across all commitment tiersyour dose may need to go up, but your price won't
Generation I Semaglutide GLP-1 only Peak Weight Loss 14.9% STEP 1 trial 68 weeks Receptor Coverage Single GLP-1 FDA Status Approved (Wegovy, 2021) FIRST PUBLISHED Wilding et al., NEJM 2021 Generation II Tirzepatide GLP-1 + GIP Peak Weight Loss 22.5% SURMOUNT-1 trial 72 weeks Receptor Coverage Dual GLP-1, GIP FDA Status Approved (Zepbound, 2023) First Published Jastreboff et al., NEJM 2022 Generation III Retatrutide GLP-1 + GIP + GCGR Peak Weight Loss 24.2% Phase 2 48 weeks (highest dose) Receptor Coverage Triple GLP-1, GIP, GCGR FDA Status Phase 3 (TRIUMPH program) First Published Jastreboff et al., NEJM 2023 -SELECTED LITERATURE Key Retatrutide research and clinical publications
New to GLP-1 medications Sensitive to nausea or GI side effects Goal is maintenance, not aggressive loss Biohacker or metabolic optimization focus Prefer a slower, more sustainable protocol The standard titration schedule used in clinical settings
You are going from three active pathways to two, which your body already recognizes from the retatrutide experience
ZhangJ.XieX
